Johnson and Johnson recently received approval from the FDA to market one of their newest drugs, Nucynta ER. This extended-release pill is intended to be used for those suffering from moderate to sever chronic pain. This drug will be available under a risk management strategy, in which consumers will be informed of the dangers of drug abuse and misuse, overdose, and addiction.
Attorney Doug Stoehr is a personal injury lawyer serving western and central PA. If you would like to consult with him about a possible claim, please contact our law office.